Fen EP Ltd is developing instrumentation for the prediction of sudden cardiac death, which can be a major issue for physicians, and health care providers.
The Company’s device is intended to enable interpretation of complex data and enable clinicians to assess patients as high, medium or low risk. Patients considered low risk could then be managed by alternative methods and therefore may not need surgery.
ProductLife Sciences SEIS
SectorSudden Cardiac Death prevention